Article Text

Download PDFPDF
Clinical genomics and the adult with congenital heart disease: new opportunities
  1. Isma Rafiq,
  2. Leisa Freeman
  1. Cardiology Department, Norfolk and Norwich University Hospital, Norwich, UK
  1. Correspondence to Dr Isma Rafiq, Cardiology Department, Norfolk and Norwich University Hospital, Colney Lane, Norwich, Norfolk, Norwich NR4 7 UY, UK; ismach{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

To the Editor

We are intrigued by the article by Priest and Ashley.1 The importance of genomics has been clearly identified and the article beautifully describes the role of genetics in cardiovascular medicine but concentrates on inherited arrhythmias, cardiomyopathies and occasional pharmacogenomic profiling.1 We suggest they have failed to consider the large, unrecognised need for genomics in adults patients with congenital heart conditions.

More than 90% of patients with congenital heart conditions now survive to adulthood and yet as neonates/children there was restricted availability of genetic testing and limited techniques. When such patients attend the adult clinic they want to know the …

View Full Text


  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles

  • Editorial
    James R Priest Euan A Ashley